|
PICALM expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.136040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.449700E-02 |
| Normal-vs-Stage2 |
2.909400E-01 |
| Normal-vs-Stage3 |
3.877600E-01 |
| Normal-vs-Stage4 |
4.345600E-01 |
| Stage1-vs-Stage2 |
1.031940E-02 |
| Stage1-vs-Stage3 |
3.571600E-01 |
| Stage1-vs-Stage4 |
5.782200E-01 |
| Stage2-vs-Stage3 |
1.106970E-01 |
| Stage2-vs-Stage4 |
1.374820E-01 |
| Stage3-vs-Stage4 |
9.049800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.064170E-01 |
| Normal-vs-AfricanAmerican |
1.526640E-01 |
| Normal-vs-Asian |
1.925370E-01 |
| Caucasian-vs-AfricanAmerican |
4.761600E-01 |
| Caucasian-vs-Asian |
9.334000E-01 |
| AfricanAmerican-vs-Asian |
4.947400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.340400E-01 |
| Normal-vs-Female |
1.240650E-01 |
| Male-vs-Female |
9.872400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.204400E-03 |
| Normal-vs-Age(41-60Yrs) |
5.989400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.033400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.933400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.711630E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.737930E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.145800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.756000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.613600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.455400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.641600E-01 |
| Classical-VS-Follicular |
7.85230000022175E-07 |
| Classical-VS-Other |
6.253600E-01 |
| Classical-VS-Normal |
5.136600E-03 |
| Tall-VS-Follicular |
2.480900E-03 |
| Tall-VS-Other |
6.087800E-01 |
| Tall-VS-Normal |
1.047970E-01 |
| Follicular-VS-Other |
2.457000E-01 |
| Follicular-VS-Normal |
4.807700E-02 |
| Other-VS-Normal |
6.222600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.900400E-01 |
| Normal-vs-N1 |
2.924000E-01 |
| N0-vs-N1 |
1.107040E-01 |
|
|
